ATE475640T1 - Antagonisten des opioidrezeptors - Google Patents

Antagonisten des opioidrezeptors

Info

Publication number
ATE475640T1
ATE475640T1 AT05724567T AT05724567T ATE475640T1 AT E475640 T1 ATE475640 T1 AT E475640T1 AT 05724567 T AT05724567 T AT 05724567T AT 05724567 T AT05724567 T AT 05724567T AT E475640 T1 ATE475640 T1 AT E475640T1
Authority
AT
Austria
Prior art keywords
sup
antagonists
opioid receptor
racemate
diastereomer
Prior art date
Application number
AT05724567T
Other languages
English (en)
Inventor
La Torre Marta Garcia De
Charles Mitch
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE475640T1 publication Critical patent/ATE475640T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
AT05724567T 2004-03-12 2005-03-08 Antagonisten des opioidrezeptors ATE475640T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04380058 2004-03-12
US55318404P 2004-03-15 2004-03-15
PCT/US2005/007051 WO2005090286A1 (en) 2004-03-12 2005-03-08 Opioid receptor antagonists

Publications (1)

Publication Number Publication Date
ATE475640T1 true ATE475640T1 (de) 2010-08-15

Family

ID=34961741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05724567T ATE475640T1 (de) 2004-03-12 2005-03-08 Antagonisten des opioidrezeptors

Country Status (7)

Country Link
US (1) US7381750B2 (de)
EP (1) EP1727788B1 (de)
AT (1) ATE475640T1 (de)
CA (1) CA2558568A1 (de)
DE (1) DE602005022572D1 (de)
ES (1) ES2347577T3 (de)
WO (1) WO2005090286A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381719B2 (en) * 2002-09-19 2008-06-03 Eli Lilly And Company Diaryl ethers as opioid receptor antagonist
EP1751103B1 (de) 2004-03-15 2009-01-14 Eli Lilly And Company 4-(5-(aminomethyl)-indol-1-ylmethyl)benzamidderivate und verwandte verbindungen als opioidrezeptorantagonisten zur behandlung von fettleibigkeit
CN101511808A (zh) 2006-09-08 2009-08-19 辉瑞产品公司 二芳基醚衍生物及其用途
EP2152671A1 (de) 2007-05-22 2010-02-17 Prosidion Limited Bicyclische aryl- und heteroarylverbindungen zur behandlung von stoffwechselerkrankungen
EP2197835A1 (de) 2007-09-07 2010-06-23 Prosidion Limited Bicyclische aryl- und heteroarylverbindungen als rezeptormodulatoren
MY163014A (en) * 2008-01-22 2017-07-31 Lilly Co Eli Kappa selective opioid receptor antogonist
CN102695508A (zh) * 2009-09-18 2012-09-26 阿得罗公司 阿片样受体拮抗剂用于胃肠道疾病的用途
US8309064B2 (en) 2009-11-09 2012-11-13 Conopco, Inc. Skin care compositions comprising phenoxyalkyl amines
US8425885B2 (en) * 2009-11-09 2013-04-23 Conopco, Inc. Substituted 3-(phenoxymethyl) benzyl amines and personal care compositions
EP3037408A4 (de) * 2013-08-23 2017-03-08 Ishihara Sangyo Kaisha, Ltd. Mittel zur bekämpfung schädlicher organismen
CN107624110B (zh) 2015-03-06 2021-01-26 法玛克亚公司 赖氨酰氧化酶样2抑制剂及其用途
EA034891B1 (ru) 2015-03-06 2020-04-02 Фармакеа, Инк. Фторированные ингибиторы лизилоксидазоподобного фермента-2 и их применение
EP3509594B1 (de) 2016-09-07 2025-02-26 Pharmakea, Inc. Lysyloxidase-like 2-inhibitor zur verwendung in der behandlung von myelofibrose
CA3036064A1 (en) 2016-09-07 2018-03-15 Pharmakea, Inc. Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making
US12161622B2 (en) 2021-05-04 2024-12-10 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
IL315409A (en) 2022-03-07 2024-11-01 Janssen Pharmaceuticals Inc Polymorph forms of aticaprant for use in treating major depressive disorder
IL315415A (en) 2022-03-07 2024-11-01 Janssen Pharmaceuticals Inc The compositions containing eticarpant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA754192B (en) 1974-08-05 1976-06-30 Ciba Geigy Ag 2-(aralkoxyphenyl)-1-(bis-arylalkylamino)-alkanes
GB9104656D0 (en) 1991-03-05 1991-04-17 Zambeletti Spa L Pharmaceuticals
GB9417532D0 (en) 1994-08-31 1994-10-19 Zeneca Ltd Aromatic compounds
BR9909666A (pt) * 1998-03-26 2001-09-11 Japan Tobacco Inc Derivados de amida e antagonistas de nociceptina
PL220721B1 (pl) 2001-03-29 2015-12-31 Lilly Co Eli Związki będące pochodnymi N-(indolilo-2-etylo) benzyloaminy, kompozycja farmaceutyczna oraz zastosowanie
US7381719B2 (en) * 2002-09-19 2008-06-03 Eli Lilly And Company Diaryl ethers as opioid receptor antagonist
US7396943B2 (en) 2003-03-07 2008-07-08 Eli Lilly And Company Opioid receptor antagonists
DE10317098A1 (de) 2003-04-14 2004-07-22 Infineon Technologies Ag Verfahren zur Herstellung eines Bipolartransistors
EP1697307B1 (de) 2003-12-12 2014-03-12 Eli Lilly & Company Antagonisten des opioidrezeptors
US7414132B2 (en) 2003-12-22 2008-08-19 Eli Lilly And Company Opioid receptor antagonists

Also Published As

Publication number Publication date
US7381750B2 (en) 2008-06-03
EP1727788B1 (de) 2010-07-28
DE602005022572D1 (de) 2010-09-09
EP1727788A1 (de) 2006-12-06
CA2558568A1 (en) 2005-09-29
ES2347577T3 (es) 2010-11-02
US20070287751A1 (en) 2007-12-13
WO2005090286B1 (en) 2005-12-22
WO2005090286A1 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
ATE545413T1 (de) Antagonisten des opioidrezeptors
MY140236A (en) Diarylether compounds useful as opioid receptor antagonists
ATE475640T1 (de) Antagonisten des opioidrezeptors
MXPA05009367A (es) Antagonistas del receptor opioide.
TW200716520A (en) 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
MX2009004900A (es) Arilamidas sustituidas por tiazol u oxazol.
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
WO2002074758A3 (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications
MX2009004096A (es) Metabolitos de talarozol.
TNSN07349A1 (fr) Derives de n-(n-sulfonylaminomethyl) cyclopropanecarboxamide utiles pour le traitement de la douleur
TW200716574A (en) The preparation and use of compounds as aspartyl protease inhibitors
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
WO2004000808A3 (en) N-substituted piperidine derivatives as serotonin receptor agents
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
DE602005017423D1 (de) Thiazolopyridinon-derivate als mch-rezeptorantagonisten
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
ATE308522T1 (de) Opioidrezeptorantagonisten
PL1828177T3 (pl) Nowi antagoniści receptora MCH
WO2006113552A8 (en) Cyanoarylamines
MX2008001606A (es) Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico.
TW200716547A (en) Piperidin-4-yl-amide derivatives
ATE399164T1 (de) Antagonisten des opioidrezeptors
WO2004080411A3 (en) Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
TW200621223A (en) Acyclic 1,3-diamines and uses therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties